AChR-Ab Seropositive Generalized Myasthenia Gravis Clinical Trials
2 recruiting trials for AChR-Ab Seropositive Generalized Myasthenia Gravis. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
1
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT07284420
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With...
This study is part of the ADAPT Forward platform study (NCT07294170). ADAPT Forward is a platform study with the aim to look at how safe different drugs are and how well they work...
Sponsor: argenxEnrolling: 705 locations
RECRUITINGNCT07294170
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in...
ADAPT Forward is a platform study with the aim to look at how safe different drugs are and how well they work for people with myasthenia gravis. The goal is to find the best...
Sponsor: argenxEnrolling: 705 locations